Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Higher immunoglobulin G antibody levels against cytomegalovirus are associated with incident ischemic heart disease in the population-based EPIC-Norfolk cohort.

Gkrania-Klotsas E, Langenberg C, Sharp SJ, Luben R, Khaw KT, Wareham NJ.

J Infect Dis. 2012 Dec 15;206(12):1897-903. doi: 10.1093/infdis/jis620. Epub 2012 Oct 8.

PMID:
23045624
2.

Seropositivity and higher immunoglobulin g antibody levels against cytomegalovirus are associated with mortality in the population-based European prospective investigation of Cancer-Norfolk cohort.

Gkrania-Klotsas E, Langenberg C, Sharp SJ, Luben R, Khaw KT, Wareham NJ.

Clin Infect Dis. 2013 May;56(10):1421-7. doi: 10.1093/cid/cit083. Epub 2013 Feb 26.

3.

Risk factors for cytomegalovirus reactivation after liver transplantation: can pre-transplant cytomegalovirus antibody titers predict outcome?

Bruminhent J, Thongprayoon C, Dierkhising RA, Kremers WK, Theel ES, Razonable RR.

Liver Transpl. 2015 Apr;21(4):539-46. doi: 10.1002/lt.24078. Epub 2015 Mar 12.

4.

Cytomegalovirus infection and the risk of mortality and frailty in older women: a prospective observational cohort study.

Wang GC, Kao WH, Murakami P, Xue QL, Chiou RB, Detrick B, McDyer JF, Semba RD, Casolaro V, Walston JD, Fried LP.

Am J Epidemiol. 2010 May 15;171(10):1144-52. doi: 10.1093/aje/kwq062. Epub 2010 Apr 16.

5.

Cytomegalovirus antibody levels, inflammation, and mortality among elderly Latinos over 9 years of follow-up.

Roberts ET, Haan MN, Dowd JB, Aiello AE.

Am J Epidemiol. 2010 Aug 15;172(4):363-71. doi: 10.1093/aje/kwq177. Epub 2010 Jul 21.

6.

Cytomegalovirus seropositivity and incident ischaemic heart disease in the Caerphilly prospective heart disease study.

Strachan DP, Carrington D, Mendall MA, Butland BK, Sweetnam PM, Elwood PC.

Heart. 1999 Mar;81(3):248-51.

7.

Role of cytomegalovirus sero-status in the development of secondary cardiovascular events in patients with coronary heart disease under special consideration of diabetes.

Guech-Ongey M, Brenner H, Twardella D, Hahmann H, Rothenbacher D.

Int J Cardiol. 2006 Jul 28;111(1):98-103. Epub 2005 Oct 17.

PMID:
16229909
8.

A prospective study of cytomegalovirus, herpes simplex virus 1, and coronary heart disease: the atherosclerosis risk in communities (ARIC) study.

Sorlie PD, Nieto FJ, Adam E, Folsom AR, Shahar E, Massing M.

Arch Intern Med. 2000 Jul 10;160(13):2027-32.

PMID:
10888976
9.

Simultaneous monitoring of cytomegalovirus-specific antibody and T-cell levels in seropositive heart transplant recipients.

Carbone J, Lanio N, Gallego A, Kern F, Navarro J, Muñoz P, Alonso R, Catalán P, Fernández-Yáñez J, Palomo J, Ruiz M, Fernández-Cruz E, Sarmiento E.

J Clin Immunol. 2012 Aug;32(4):809-19. doi: 10.1007/s10875-012-9670-7. Epub 2012 Feb 29.

PMID:
22371292
10.

National prevalence estimates for cytomegalovirus IgM and IgG avidity and association between high IgM antibody titer and low IgG avidity.

Dollard SC, Staras SA, Amin MM, Schmid DS, Cannon MJ.

Clin Vaccine Immunol. 2011 Nov;18(11):1895-9. doi: 10.1128/CVI.05228-11. Epub 2011 Sep 14.

11.

High seropositivity of IgG and IgM antibodies against cytomegalovirus (CMV) among HIV-1 seropositive patients in Ilorin, Nigeria.

Fowotade A, Okonko IO, Agbede OO, Suleiman ST.

Afr Health Sci. 2015 Mar;15(1):1-9. doi: 10.4314/ahs.v15i1.1.

12.

Cytomegalovirus seroprevalence among solid organ donors in Hungary: correlations with age, gender, and blood group.

Varga M, Görög D, Kári D, Környei E, Kis É, Túryné HJ, Jankovics I, Péter A, Toronyi É, Sárváry E, Fazakas J, Reusz G.

Transplant Proc. 2011 May;43(4):1233-5. doi: 10.1016/j.transproceed.2011.03.067.

PMID:
21620098
13.

Seroprevalence of cytomegalovirus IgG antibodies among pregnant women in Japan from 2009-2014.

Shigemi D, Yamaguchi S, Otsuka T, Kamoi S, Takeshita T.

Am J Infect Control. 2015 Nov;43(11):1218-21. doi: 10.1016/j.ajic.2015.06.026. Epub 2015 Aug 12.

PMID:
26277571
14.

Cross-sectional study of cytomegalovirus shedding and immunological markers among seropositive children and their mothers.

Stowell JD, Mask K, Amin M, Clark R, Levis D, Hendley W, Lanzieri TM, Dollard SC, Cannon MJ.

BMC Infect Dis. 2014 Nov 12;14:568. doi: 10.1186/s12879-014-0568-2.

15.
16.

Is screening for IgG antibody to cytomegalovirus and Epstein-Barr virus infections mandatory in potential renal transplant recipients and donors in Iran?

Saghafi H, Qorashi M, Heidari A.

Transplant Proc. 2009 Sep;41(7):2761-3. doi: 10.1016/j.transproceed.2009.07.057.

PMID:
19765428
17.

Cytomegalovirus immunoglobulin G antibody is associated with subclinical carotid artery disease among HIV-infected women.

Parrinello CM, Sinclair E, Landay AL, Lurain N, Sharrett AR, Gange SJ, Xue X, Hunt PW, Deeks SG, Hodis HN, Kaplan RC.

J Infect Dis. 2012 Jun 15;205(12):1788-96. doi: 10.1093/infdis/jis276. Epub 2012 Apr 5.

18.

Serologic screening of pregnant Korean women for primary human cytomegalovirus infection using IgG avidity test.

Seo S, Cho Y, Park J.

Korean J Lab Med. 2009 Dec;29(6):557-62. doi: 10.3343/kjlm.2009.29.6.557.

19.

Breast cancer, cytomegalovirus and Epstein-Barr virus: a nested case-control study.

Cox B, Richardson A, Graham P, Gislefoss RE, Jellum E, Rollag H.

Br J Cancer. 2010 May 25;102(11):1665-9. doi: 10.1038/sj.bjc.6605675. Epub 2010 Apr 20.

20.

Are the high levels of cytomegalovirus antibodies a determinant in the development of coronary artery disease?

Eryol NK, Kiliç H, Gül A, Ozdogru I, Inanç T, Dogan A, Topsakal R, Basar E.

Int Heart J. 2005 Mar;46(2):205-9.

Supplemental Content

Support Center